In fact, EGFR activation contributes to the upregulation of PD‐1, PD‐L1, and CTLA‐4 expression levels as well as the decrease in T cell infiltration and reduces inflammation in the tumor microenvironment.87 The gene discussed is EGFR; the disease is neoplasm.